DERMATA THERAPEUTICS INC (DRMA:NASDAQ)
$1.22 0.01 (0.8264%)
Analysed DERMATA THERAPEUTICS INC (DRMA:NASDAQ) News Sources
Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Delivery System
02-04-2026
yahoo.com
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025
26-03-2026
yahoo.com
Dermata Announces Appointment of Kyra Peckaitis as Vice President, Marketing
10-03-2026
yahoo.com
Dermata Opens a New Chapter with the Release of Tome Skincare
05-03-2026
yahoo.com
Dermata Receives Notice of Grant of Patent for Next-Generation Acne Treatment by Australian Patent Office
20-01-2026
yahoo.com
Dermata Therapeutics Announces Closing of up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
29-12-2025
yahoo.com
Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
24-12-2025
yahoo.com
A New Realm of Skincare is Coming: Dermata Teases New OTC Brand Identity
04-12-2025
yahoo.com
Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results
14-11-2025
yahoo.com
Dermata Announces Acceptance of Patent Application for Next-Generation Acne Treatment by Australian Patent Office
02-10-2025
yahoo.com
What is the current price of DERMATA THERAPEUTICS INC (DRMA:NASDAQ)?
The current price of DERMATA THERAPEUTICS INC (DRMA:NASDAQ) is $1.22.
DERMATA THERAPEUTICS INC (DRMA:NASDAQ) absolute price change since previous trading day?
The absolute price change of DERMATA THERAPEUTICS INC (DRMA:NASDAQ) since the previous trading day is $0.01.
DERMATA THERAPEUTICS INC (DRMA:NASDAQ) percentage price change since previous trading day?
The percentage price change of DERMATA THERAPEUTICS INC (DRMA:NASDAQ) since the previous trading day is 0.8264%.
What is the most recent average sentiment score for DERMATA THERAPEUTICS INC (DRMA:NASDAQ)?
The most recent average sentiment score for DERMATA THERAPEUTICS INC (DRMA:NASDAQ) is 86 out of 100.
What is the most recent average sentiment for DERMATA THERAPEUTICS INC (DRMA:NASDAQ)?
The most recent sentiment for DERMATA THERAPEUTICS INC (DRMA:NASDAQ) is .
SEC-8K** Filing Available For DERMATA THERAPEUTICS INC (DRMA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.